About 140,400 obese patients in Massachusetts were prescribed medications such as Wegovy and Zepbound in 2024, a 255 percent increase from 2023, according to a Globe analysis of insurance claims data compiled by Real Chemistry, a health analytics firm
There is absolutely no scientific evidence that GLP-1 patches or "Mounjaro patches" work to help you lose weight
No affiliation with Novo Nordisk Inc., the only US source of FDA-approved semaglutide
While the 2025 Employer Health Benefit Survey finds there was a notable increase in the share of the largest firms (5,000+) that cover GLP-1 medications for weight loss, the conversations with employers highlight their concerns about the cost of these medications
How do you evaluate and treat a dysfunctional gut
Show clinic rate comparisons as backing